Dune Medical Devices, a Westborough, MA-based provider of medical device for real-time breast cancer detection, has completed the first of a two stage $21m equity financing.
The initial closing was completed for $14m with a second tranche of $7m to be completed by October 2014.
Backers included the Kraft Group and Canepa Advanced Healthcare Fund, among others.
The company intends to use the funds to expand the sales and marketing efforts for Dune’s first product, the MarginProbe System.
Led by CEO Dr. Dan Hashimshony, Dune Medical Devices provides the MarginProbe System, which enables real time detection of cancer at the surface of excised tissue specimens during surgery for breast cancer.
FinSMEs
26/06/2014